Belinda Hardin, PharmD (she/her/hers)

Director, Medical Communications
Lexicon Pharmaceuticals

M. Belinda Hardin, PharmD, BCPS, is Director of Medical Communications at Lexicon Pharmaceutical, INC. She received her Doctorate of Pharmacy from Auburn University, completed an ASHP Accredited Pharmacy Residency, and maintains Board Certification in Pharmacotherapy from the Board of Pharmacy Specialities. Additionally, she is a certified Continuous Improvement Practioner. .

Disclosure information not submitted.

Presentation(s):

• P103 - Efficacy and Safety of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, in Patients with Type 1Diabetes and Chronic Kidney Disease: A Post-Hoc Analysis of the inTandem Studies

  Saturday, August 10, 2024
  12:15 PM – 1:15 PM CT

• P104 - Impact of Sotagliflozin, a Dual Sodium-Glucose Cotransporter 1-2 Inhibitor, as Add-on to Inadequately Controlled Basal Insulin-Treated Type 2 Diabetes

  Saturday, August 10, 2024
  12:15 PM – 1:15 PM CT

• P105 - Patient Reported Burden of Disease in Diabetic Peripheral Neuropathic Pain: Learnings from In-depth Patient Interviews, Sub-Study of RELIEF-DPN 1

  Saturday, August 10, 2024
  12:15 PM – 1:15 PM CT